Industry News
New device offers a simpler and potentially less expensive way to detect DNA and other biomolecules
1/15/2015
A simple method to sense DNA, as well as potential biomarker proteins of cancer or other diseases such as Alzheimer's, may soon be within reach - thanks to the work of a team of Yokohama National...
Breast cancer: rates of diagnosis and survival 'vary by race'
1/15/2015
A new study finds the likelihood of women in the US being diagnosed with breast cancer at stage I and surviving the diagnosis varies by race and ethnicity.
Mechanism discovered that leads to drug resistance, metastasis in melanoma
1/15/2015
Moffitt Cancer Center researchers have discovered a mechanism that leads to resistance to targeted therapy in melanoma patients and are investigating strategies to counteract it.
New target identified for potential brain cancer therapies
1/15/2015
Researchers from Virginia Commonwealth University (VCU) Massey Cancer Center and the VCU Institute for Molecular Medicine (VIMM) have identified a new protein-protein interaction that could serve as...
Study identifies breast cancer diagnosis, survival variations by race, ethnicity
1/15/2015
A new study finds the likelihood of women in the US being diagnosed with breast cancer at stage I and surviving the diagnosis varies by race and ethnicity.
The impact of inflammation and cytokine biology on many aspects of breast cancer
1/15/2015
Emerging data on the role of inflammation and the immune system in the development, growth, and spread of breast tumors have focused increased attention on the role cytokines such as interleukin and...
What are the health benefits of biotin?
1/15/2015
Find out about the potential health benefits of biotin including assisting with a healthy pregnancy, improving nail strength and durability, and lowering blood glucose.
Mechanism discovered that leads to drug resistance, metastasis in melanoma
1/15/2015
Moffitt Cancer Center researchers have discovered a mechanism that leads to resistance to targeted therapy in melanoma patients and are investigating strategies to counteract it.
Cornerstone Pharmaceuticals, Inc., a clinical stage company and leader in the field of cancer metabolism-based therapeutics, has announced the initiation of a Phase I clinical trial of CPI-613, in...
Biochemically modified constituent of yew demonstrates early effectiveness in bile duct cancer
1/14/2015
Bile duct cancers are amongst the most aggressive tumour-related diseases and, so far, the medical treatment options available have been limited.